This site is intended for Healthcare Professionals only.

DHSC publishes second list of March price concessions

Date:

Share post:

The Department of Health and Social Care on Thursday announced the second list of drug price concessions for March.

The list of prices, revealed by PSNC, is below. The negotiator said it is working on further concessionary prices on other drugs reported to be unavailable at the stated March 2020 Drug Tariff price.

The first list announced on 13 March can be seen here.

Drug Pack size Price concession
Amiloride 5mg tablets 28 £27.50
Clonidine 25microgram tablets 112 £14.44
Co-careldopa 25mg/100mg tablets 100 £12.88
Cyanocobalamin 50microgram tablets 50 £9.84
Desmopressin 200microgram tablets 30 £22.70
Esomeprazole 20mg gastro-resistant capsules 28 £2.42
Fluoxetine 10mg capsules 30 £46.70
Fluoxetine 60mg capsules 30 £6.99
Lamotrigine 25mg dispersible tablets sugar free 56 £7.74
Meloxicam 7.5mg tablets 30 £3.15
Meloxicam 15mg tablets 30 £5.80
Perindopril erbumine 4mg tablets 30 £4.30
Pizotifen 1.5mg tablets 28 £5.35
Ranitidine 150mg tablets 60 £7.32
Ranitidine 300mg tablets 30 £6.80
Tacrolimus 0.1% ointment 30g £18.20
Tolterodine 1mg tablets 56 £22.80
Tolterodine 2mg tablets 56 £23.99
Venlafaxine 75mg tablets 56 £14.22

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...

UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition

Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects   British pharmacies and slimming...

MHRA says many online pharmacies are ‘unregulated’,’ illegal’, or ‘fraudulent’

MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds The Medicines and Healthcare products...

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...